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The active middle ear implant (AMEI) may be considered, in selected cases, a 
valid alternative to conventional hearing aids (cHA) for rehabilitation of bilateral 
sensorineural hearing loss (SNHL). Since 2007, at the Implanting Centre of the 
University Hospital Sant’Andrea in Rome, 43 subjects underwent surgery for appli-
cation of the Esteem®, after ascertaining by CT scan its feasibility for allocating its 
transducers within the mastoid space. The surgical procedure is longer than for the 
other AMEI, and the switch on of the device is usually performed 4–6 weeks after 
surgery. All the Esteem® implantees underwent a pre- and postoperative assessment 
via pure tone and speech audiometry with headset in a soundproof booth. Along 
with the recommended population with moderate-to-severe hearing loss, subjects 
also with a worse hearing loss (severe or severe-to-profound) were selected for this 
implant for different reasons. The auditory outcome in label and off-label implan-
tees was analyzed. Complications included the need for a minor revision, due to 
middle ear fibrosis, or for an explant that was followed by ossicular reconstruction 
with return to a cHA (two subjects), cochlear implantation (five subjects) or no 
alternative solution (one case).
Keywords: Esteem, active middle ear implant, fully-implantable device, 
sensorineural hearing loss, hearing rehabilitation
1. Introduction
Active middle ear implants (AMEI) represents today one of the possible reha-
bilitative solutions for hearing-impaired individuals. These devices utilize, for their 
function, a vibratory effect instead of the classical, physiological air-conducted 
sound stimulation. This natural sound transmission way, if warranting the perfect 
solution under normal hearing conditions, usually generates several negative issues 
on a hearing-impaired ear, going from an insufficient stimulation to the presence 
of distortions when the conventional hearing amplifiers, i.e. hearing aids (HA), 
are in use. In fact, despite their striking technological improvement over the last 
decades (advanced miniaturization, open-fitting systems, sophisticated digital 
signal processing software, and wide connectivity), the latter are rarely showing 
to be optimal for the patients’ auditory needs while generating distorted amplifica-
tion issues (feedback, occlusion effect, and insufficient high-frequency gain). As 
a consequence, the number of HA users is far from equaling the purchased devices 
worldwide. Another playing factor is due to the scarce impact on some quality of 
life issues (manual difficulty, stigma, pathology, or reduced caliber of the external 
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auditory canal, earmold allergies, and impossibility to use them during water 
contact, physical activities, and overnight, while sleeping).
The advent of AMEI with the stimulation pathway different from the normal (or 
amplified) sound, i.e., the electromechanical one, has paved the way for the pos-
sible theoretical resolution of the above-mentioned annoying cHA-related issues. 
In fact, these devices are directly coupled to middle or inner ear elements (ossicular 
chain or part of it, round window membrane) for achieving close-field cochlear 
stimulation, and should theoretically overcome most of the issues deriving from 
the obligatory acoustic over-stimulation that needs to be delivered by an external 
amplifier, such as a cHA. Moreover, all of them leave the external ear canal free, so 
as to improve the auditory and physical occlusion issues, as well as the compatibility 
with external ear canal or middle ear pathologies.
In relation to the presence of an external component, the AMEI can be distin-
guished in semi- or fully implantable devices, this latter term inherently meaning 
that all their components remain completely invisible under the skin. At the pres-
ent time, only two fully implantable devices are available for the rehabilitation of 
sensorineural hearing loss (SNHL): the Carina® (Cochlear, Lane Cove, Australia) 
and the Esteem® (Envoy Medical Corporation, St. Paul, MN, USA). Both devices 
have in common the complete allocation inside the skull, while carrying at the same 
time some major differences, as listed in Table 1.
This last appealing factor is surely playing an important role for the decision-
making process while counseling with a possible candidate, but it would not be wise 
to consider it as primary factor for its choice, and anyhow never replacing a preop-
erative use or trial with a best-fitted last-generation digital cHA.
At Sant’Andrea University Hospital, Rome, Italy, an extensive rehabilitative 
program for hearing impairment has been applied since nearly 15 years, mostly 
aiming at the resolution of different types and severity of conductive, mixed and 
SNHL. In particular, from 2007, a series of subjects affected by bilateral SNHL 
have undergone Esteem® surgical application. The Esteem® (Envoy Medical, St 
Paul, MN, USA) middle ear implant has recently been reported to be beneficial for 
individuals affected by moderate-to-severe bilateral SNHL, with low morbidity and 
complication rate [1, 2]. This device works via a piezoelectric vibratory stimulus on 
the stapes and thereafter to the inner ear fluids, also vibrating the intact eardrum 
that plays as natural microphone. Following this physiological route, a natural 
sound quality is likely to be perceived by preserving auricular filtering (at high 
frequencies) and leaving the ear canal open, thus eliminating the occlusion effect.
The aim of the present report is to highlight specific clinical issues including 
those that have emerged while following up the Esteem®-implanted patients over 
several years. In particular, special attention is devoted to the surgical procedure; to 
the functional outcome, also in comparison with the performance with cHA, and 
its impact on the quality of life; to the battery, in terms of its variable duration and 
surgical replacement; and, finally, to the complication occurrence and rate.
Essential features of fully implantable AMEI
Microphone Battery Stimulation FDA approval (by 
June 2019)
Esteem No Periodic surgical 
change
Piezoelectric Yes
Carina Yes Daily recharge Electromagnetic No
Table 1. 
Features of the two fully implantable hearing systems available today; FDA: Food and Drug Administration.
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The implantable components of the Esteem® are represented by a sound proces-
sor (SP), powered by a nonrechargeable battery, and two piezoelectric transducers, 
i.e., the sensor and the actuator (driver) (Figure 1).
The SP titanium case is housed in a temporal bone niche and receives the elec-
trical signals from the sensor cemented to the incus body. After being processed, 
the signals are sent to the driver cemented to the stapes head, with a vibrational 
movement that generates the perilymphatic wave for cochlear stimulation 
(Figure 2).
The Envoy Medical Company recommendations for candidacy include moderate 
to severe types of SNHL whilst its application is discouraged in patients with word 
recognition score (WRS) in quiet inferior to 40%. Nevertheless, recent reports have 
shown that Esteem® may provide large amplification ranges up to 2–4 kHz, regard-
less of degree of hearing loss [3].
Figure 1. 
The Esteem® middle ear implant. The sound processor is connected to the two transducers, namely the sensor 
and the driver.
Figure 2. 
The two transducers connected to the sound processor (2) are then placed in contact with the ossicular chain: 
The sensor (1) to the incus body and the driver (3) to the stapes head.
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2. Material and methods
All selected candidates were implanted with the Esteem® AMEI. Potential 
candidates were selected after a thorough audiometric assessment, which included 
pure tone and speech audiometry. In accordance with the Envoy Medical data, the 
advised threshold range is that reported in Figure 3, with a speech discrimination 
score better than 40%.
Once the audiological clearance is given, a preliminary CT scan of the petrous 
bone is carried out to assess the feasibility of the procedure, in particular, if the 
space inside the mastoid cavity would be sufficient for housing the two transducers: 
the sensor on the incus body, by measuring the distance between the incus body and 
the sino-dural angle, and the driver on the stapes head, through a wide posterior 
tympanotomy, going posteriorly toward the sigmoid sinus region and lateral to the 
mastoid facial nerve course. At this point, all the information regarding use, time 
of use, and performances with a cHA is taken and thoroughly evaluated by speech 
audiometry in quiet and noise as well as by specific questionnaires.
The surgical procedure is performed under general anesthesia, with facial nerve 
monitoring and under hypotensive control all along the surgical steps, especially 
when cementing is taking place. The main steps of the surgical procedure are sum-
marized as follows:
1. Identification of a flat, retro-auricular area in which a bony niche for the sound 
processor (SP) can be drilled. Accordingly, the skin incision is outlined and 
injected with vasoconstrictor solution.
2. A lazy-C retro-auricular incision, including skin and subcutaneous tissue, is 
carried out. After placement of self-retaining retractors, a large Palva flap is 
created and elevated with an anteriorly based pedicle. The SP bone well is then 
drilled by using large (6–8 mm) cutting and diamond burs, ending up by drill-
ing two small holes on both sides for securing the SP to the skull at the end of 
surgery by nylon thread.
3. An enlarged mastoidectomy is then drilled, completely exposing the presig-
moid area, the sino-dural angle, and the inferior mastoid cell tip area.
Figure 3. 
The audiometric range of indication for the Esteem® fully implantable hearing device.
5The Esteem®, Fully Implantable Middle Ear Device
DOI: http://dx.doi.org/10.5772/intechopen.89250
4. Posterior epitympanectomy is then carried out until getting the complete 
exposure of the incus body and the malleus head, with the incudomalleolar 
joint.
5. Posterior tympanotomy is then drilled, thinning out—but keeping intact—the 
posterior buttress; drilling is continued until a gross trapezoidal-shaped open-
ing is obtained at the expense of the chorda tympani nerve, which needs to 
be severed in all cases to avoid its eventual contact with the driver transducer. 
The lateral aspect of the posterior tympanotomy will correspond to the fibrous 
tympanic annulus. The superior corner of the posterior tympanotomy is drilled 
until obtaining an acute angle. The whole long process of the incus and the 
pyramidal eminence needs to be optimally visualized.
6. After placing a soft insert microphone—connected to a laser Doppler vibrom-
eter (LDV) System—into the external auditory canal, two small reflectors are 
placed on the incus body and on the posterior crus of stapes for allowing the as-
sessment of the normal mobility of the intact ossicular chain [4]. LDV, mounted 
on a second microscope, checks first the intact chain movement, which should 
mandatorily give normal values before continuing the procedure. LDV is a very 
accurate (G1 10 j4 Km), noncontact instrument that works by comparing the 
frequency of the emitted laser diode light with the frequency of the reflected 
light of the moving object (Figure 4). Sound at 100-dB SPL and a sweep of 50 
frequencies ranging from 125 to 8.000 Hz are used.
7. Separation of the incudostapedial joint is performed after gently removing the 
overlying mucosa.
8. By diode laser, then, part of the long incus process is sectioned.
9. At this point, removal by scraping of the mucosa over the stapes head is ac-
complished after dying the area with methylene blue, and finally drying it with 
low-watt laser beam.
10. A drop of EnvoyCem® (a bioglass type of biological cement) is then applied on 
the stapes head, so that a “precoat” is obtained.
11. Both sensor and drivers transducers are then attached to the Glasscock stabiliz-
ers screwed on the posterior edge of the mastoidectomy cavity and are then 
placed on the incus body and on the precoated stapes head, respectively.
12. MedCem® (an hydroxyapatite type of biological cement) is then composed 
and syringed into the mastoidectomy cavity for keeping and permanently fix-
ing the transducers’ bodies in place.
13. A small drop of EnvoyCem® is then placed to cement the tip of the driver on 
the precoated stapes capitulum, as well as between the sensor tip and the incus 
body, followed by creation of a new joint (detachment of the cemented sensor 
tip from the incus body).
14. Laser Doppler vibrometer (LDV) measurements are then performed, for test-
ing both sensor and driver efficiency.
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15. The SP is then put in place and attached to the sensor and driver cables. Final 
LDV measurements of the whole system are then carried out and precede the 
end of surgery with a three-layer closure.
A bandage is then wrapped around the head and kept for 24 h. The implant is 
activated approximately 2 months after surgery, with the first fitting session, and 
later upgraded every 3 months during the first postoperative year.
Once required, the SP will be substituted via a minor surgical procedure, often-
times performed under local anesthesia. The procedure entails a C-shaped, 5-cm long 
skin incision behind the SP that is subsequently exposed to allow first the disconnec-
tion from the cables of the two transducers, then their reconnection to the new SP.
3. Results
Eighty-two surgeries were performed in total, being 46 as primary interven-
tion, 6 explantation, 4 revisions, and 27 battery changes. In three of the 46 primary 
surgeries, the procedure was interrupted due to low motility of the ossicular chain 
as shown by LDV in two cases and insufficient mastoid space in one case. So, the 
overall number of implants was 43. Implantation was always performed unilaterally, 
in the worse functioning ear of bilaterally hearing-impaired subjects; one subject 
was implanted while presenting with a unilateral severe SNHL. Bilateral application 
was completed in two subjects. Revision surgery was needed in three subjects for 
a developed fibrous tissue formation that impeded the normal movement of the 
ossicular chain and the transducers.
The outcome from Esteem® implantation has been analyzed taking into account 
several aspects, going from (a) the auditory improvement, (b) the comparison with 
the efficacy of a conventional hearing aid, (c) the patient’s quality of life, and (d) 
the complication rate and the solutions for resolving these latter.
4. Auditory improvement
The mean postoperative pure tone threshold measured between 250 and 
4000 Hz revealed an improvement of 5–10 dB in 9 subjects, 11–20 dB in 17 cases, 
21–30 dB in 5 cases, and more than 30 dB in 3 cases. A −10/−20-dB deterioration 
was found in two subjects, and a −5/−10-dB deterioration was found in three sub-
jects. Overall, more than 80% of the implanted subjects showed an improvement in 
respect to the preoperative unaided bone conduction thresholds. More specifically, 
Figure 4. 
Normative data regarding displacement of the incus (left) and stapes (right) when measured by laser Doppler 
vibrometry.
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an improved threshold at 4 kHz was measured in 62.5% of the implantees, while at 
8 kHz, it was detected in 35% of them.
4.1 Esteem vs. hearing aids
The data relative to the efficacy of the Esteem® AMEI in comparison with the 
hearing aids has already been object of a previous publication [5]. In that report, two 
groups of subjects were identified: the first one with a moderate-to-severe SNHL 
and the other one with severe-to-profound SNHL, being theoretically beyond the 
indication range limit recommended by the manufacturer (off-label). In moderate-
to-severe cases, no statistical differences with the hearing aids were shown in the 
speech-in-noise tests, while subjectively, the implanted subjects reported a higher 
level of satisfaction in terms of a better quality of life. In the severe-to-profound 
subjects, similar results were obtained so as to also consider this range of hearing 
loss, a plausible threshold for implantation, as also outlined by other investigators 
[6]. The mean gain difference in favor of the Esteem® versus a cHA was equal to 
13.1 dB, thus very similar to what previously reported by Kraus et al. [6].
4.2 Quality of life
The data relative to the quality of life issue has already been reported [7]. This 
group of patients has been pooled together with other subjects receiving different 
types of auditory implant. In total, this survey has taken into consideration the 
26 Esteem® subjects who were all asked to fill different questionnaires including 
the General Glasgow Benefit Inventory, the visual analogue scale (VAS), and the 
abbreviated profile of hearing aid benefit (APHAB). The improvement of quality 
of sound was similar to the other implanted devices, whilst the score for quality of 
life was superior to both percutaneous bone conductive implants and to the Vibrant 
Soundbridge® (Medel, Innsbruck, Austria), equaling only that measured with the 
Bonebridge® (Medel, Innsbruck, Austria).
4.3 Complications
It is important to distinguish two typologies of complications: one related to the 
surgical procedure, being inescapably part of it, and the other one as true complica-
tions. The surgical procedure implies the disconnection between incus and stapes 
so that an additional conductive component to the subject’s hearing loss is always 
postoperatively evident. The other aspect regards the need for sacrificing the 
chorda tympani nerve so that a taste disturbance could be the consequence of it. In 
this regard, however, only a very limited number of subjects reported a permanent 
dysgeusia. Finally, it has also to be considered that the need to reconstruct the 
ossicular chain should an explantation be needed. Among the true complications, 
the need for explantation occurred in six subjects: for skin dehiscence (one subject), 
loud noise (one subject), tinnitus (one subject), and hearing threshold deteriora-
tion (three subjects). Four subjects required a surgical revision and in about 9% 
of the cases, a delayed transient facial palsy was observed, with remarks that were 
object of a previous publication [8].
5. Discussion
The Esteem® fully implantable AMEI represents a real alternative to con-
ventional hearing aids when this latter one show to be inappropriate or unable 
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to provide an efficient auditory amplification and in highly selected cases. More 
specifically, with a vibratory, direct stimulation of the anatomical structures located 
close to the cochlea, such as the stapes, footplate, or round window membrane, the 
delivered energy is much lower than that required for a cHA.
The activity of the Implanting Centre at Sapienza University has been displayed 
by the application of several types of bone conductive implants and AMEI, these 
latter as semi- and fully implantable devices. Among them, the Esteem® AMEI was 
specifically considered attractive for the invisibility as well as for the absence of an 
implanted microphone. This premise has allowed us to collect the largest European 
experience since 2007, with several subjects that have reached today a long-term use 
of the device so as to allow us to draw some interesting remarks that are worth being 
shared with the interested professionals (audiologists, otologists, etc.).
First to mention is the typology of mechanical stimulation that is obtained via 
a piezoelectric modality. The bellow of both transducers is in fact made of several 
layers of crystals that are able to deliver energy when displaced, and to be displaced 
when reached by energy. Furthermore, this type of modality can be considered 
optimal for high-frequency stimulation with limited energy consumption. This lat-
ter factor explains why for the Esteem® there is no need to recharge the battery that, 
however, needs to be replaced after a certain time of use (around 5 years on average 
in our overall experience). In this regard, it has been noticed that the battery was 
more likely to be extinguished faster in case of a continuous (24/24, 7/7) use and in 
case of more advanced forms of SNHL.
The surgical procedure is somewhat demanding even for experienced otosur-
geons who must undergo laboratory training before starting with clinical applica-
tion. The complexity of the procedure is mostly related to a few, important steps 
that require the use of different types of cement, as well as to specific dexterity 
in working in very narrow spaces opened during the procedure, like for example 
when cementing the driver together with the precoated stapes head through the 
posterior tympanotomy. This is explaining why the surgical procedure can take 
long time especially with the first cases. In this regard, it is noteworthy to stress the 
importance of a bioengineer present in the operating theater, carrying out objective 
measurements by LDV during and at the end of surgery, thus offering confident 
and supporting data to the surgeon for a beneficial final functional outcome. As far 
as cement is concerned, two different types were used: a bio glass cement in small 
amounts for stapes pre-coating, incus neo-joint and stapes/driver fusion, and when 
larger amounts of cement were needed, as for stabilization of the transducers body 
within the mastoidectomy cavity, a hydroxyapatite compound was used.
Apart from the inescapable complications related to the laser resection of part 
of the incus long process and to the ablation of the chorda tympani nerve, no other 
intraoperative complications were recorded in our series. However, in less than 
10% of the subjects, delayed, transient facial nerve palsy developed, with return to 
normality in all cases within the first month after onset.
The auditory outcome has been shown to be positive in over 80% of the subjects, 
although with variable degrees of improvement. In very few cases, it has been 
necessary to perform a revision surgery for debridement of newly formed fibrous 
tissue in the middle ear that was impeding the normal motility of the transducers. 
Another interesting finding relates to the observation of a striking decrease of the 
auditory threshold (as bone conduction) observed over time especially in those 
individuals who presented an advanced SNHL, being severe-to-profound, while 
not affecting the contralateral, non-implanted ear, so as to rule out to be dependent 
upon the causative factor. This new functional situation was in some cases still 
managed by setting the Esteem SP accordingly, while in a few subjects required the 
“transition” to cochlear implantation.
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As mentioned before, the Esteem® is not requiring a daily battery recharge, 
contrary to the other fully implantable device existing today (Carina®). Therefore, 
the protocol entails a surgical substitution when the battery is going to extinguish 
(signaled by a double beep heard by the subject, a few weeks before end of the 
function). While the company mentioned a duration between 5 and 9 years, our 
personal experience showed a shorter duration, on average being 4–5 years, related 
mostly to the duration of use and to the severity of SNHL. In fact, most of the 
subjects were never switching off the device, as proof of achievement of a better 
quality of life in several daily moments (washing, bathing, sleeping, and perform-
ing physical activities). This important feature belonging to an invisible system has 
also been object of a previous report [7].
6. Conclusions
The fully implantable Esteem® active middle ear device has shown to provide a 
beneficial hearing gain in the majority of the implanted subjects. Our experience 
has shown that this may be achieved with very low morbidity as verified by the low 
incidence of complications. Other than for moderate-to-severe SNHL, the Esteem® 
may be indicated also for worse hearing threshold for which it can still provide a 
beneficial auditory and quality of life outcome. Despite its active mechanical role 
for eliciting cochlear stimulation, in certain candidates, it has been shown a pro-
gressive deterioration of the bone conduction threshold so as to limit the use of the 
implant and rather suggest cochlear implantation.
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